Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Structure-activity studies of hydroxamic acids as direct vasodilators.

H Kehl, K Fountain, T Early

    Arzneimittel-Forschung
    |January 1, 1978
    PubMed
    Summary

    New beta-hydroxylamine-phenylpropyl hydroxamic acids were found to lower blood pressure. These compounds act as direct vasodilators, not affecting major receptor systems.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Study of UltraHigh Performance Supercritical Fluid Chromatography to measure free fatty acids with out fatty acid ester preparation.

    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences·2015
    Same author

    Heart transplantation for isolated noncompaction of the left ventricle in an infant.

    The Thoracic and cardiovascular surgeon·2007
    Same author

    Coenurus serialis in a pet rabbit.

    The Veterinary record·2000
    Same author

    Malignant catatonia-induced respiratory failure with response to ECT.

    The journal of ECT·1999
    Same author

    Neuroleptic influences on a lateralized behavioral bias in unoperated rats.

    Psychopharmacology·1999
    Same author

    Male reproductive systems under chronic fluoxetine or trimipramine treatment.

    Physiology & behavior·1996

    Area of Science:

    • Pharmacology
    • Medicinal Chemistry

    Background:

    • Hypertension remains a significant global health concern.
    • Development of novel hypotensive agents is crucial for cardiovascular health.
    • Understanding drug mechanisms of action is key to therapeutic development.

    Purpose of the Study:

    • To synthesize and characterize novel beta-hydroxylamine-phenylpropyl hydroxamic acids.
    • To investigate the hypotensive potential of these synthesized compounds.
    • To elucidate the pharmacological mechanism underlying their blood pressure-lowering effects.

    Main Methods:

    • Chemical synthesis of a series of beta-hydroxylamine-phenylpropyl hydroxamic acids.
    • Pharmacodynamic studies to assess hypotensive activity in vivo.
    • Receptor binding assays to investigate interactions with adrenergic, cholinergic, and histaminergic systems.

    Main Results:

    • Successful synthesis of the target hydroxamic acid derivatives.
    • Demonstrated significant hypotensive effects mediated by the compounds.
    • Identified key structural features correlating with the observed hypotensive responses.
    • Ruled out significant interaction with adrenergic, cholinergic, and histaminergic receptors.

    Conclusions:

    • Beta-hydroxylamine-phenylpropyl hydroxamic acids represent a promising class of direct-acting vasodilators.
    • These compounds offer a potential new therapeutic avenue for managing hypertension.
    • Further research into structure-activity relationships can optimize hypotensive efficacy and safety.

    Related Experiment Videos